GTG shares soar on back of Applera lawsuit news
Monday, 20 September, 2004
The share price of Genetic Technologies (ASX: GTG) has risen over 50 per cent since the judge in GTG's lawsuit against Applera ruled largely in the company's favour during the Markman hearing last Thursday.
GTG were up from AUD$0.38 last Thursday to AUD$0.59 at time of writing.
In the hearing, the court examined 15 disputed technical terms within GTG's patent claims, ruling in favour of GTG's definition in 13 cases, and adopting a definition consistent with GTG's position for the other two terms.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
